DUBLIN--(BUSINESS WIRE)--Jun 5, 2018--The "Global Genetic Testing Market Outlook 2018-2022" report has been added to ResearchAndMarkets.com's offering.

Global Genetic Testing Market Outlook 2022 provides a detailed analysis of the genetic testing market. The report also provides an insight regarding the current and future prospective of the market.

This report covers the major trends and drivers, and their impact on the market. The report also discusses some of the restraints that can hinder the growth of the market, as well as rising opportunities which can provide new dimensions to the industry.

The advent of genetic tests has revolutionized the molecular diagnostics and cytogenetic industry. It is one of the most rapidly growing segments in the molecular diagnostics industry, which helps in delivering customized health services or personalized medicine. The share of genetic testing is incessantly increasing in the market. Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.

The segmentation of genetic testing markets has been done in the report on the basis of applications, diseases, and geographical regions.

The company profiles segment in this report is entirely devoted to profiling leading companies of the genetic testing industry including some major players like Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., Hologic, Inc., Cepheid, Agilent Technologies and QIAGEN.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Genetic Testing Overview

4. Industry Overview

5. Global Genetic Testing Market Outlook

6. Global Genetic Testing Market by Application

7. Global Genetic Testing Market by Disease

8. Global Genetic Testing Market by Geography

9. Genetic Testing Regulations

10. Mergers & Acquisitions

11. Company Profiles

Abbott Laboratories Roche Diagnostics Myriad Genetics, Inc. Thermo Fisher Scientific, Inc. Agilent Technologies, Inc. Hologic, Inc. Illumina, Inc. QIAGEN N.V. Cepheid Quest Diagnostics

For more information about this report visit https://www.researchandmarkets.com/research/mwrf2k/global_genetic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180605005936/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/05/2018 08:05 AM/DISC: 06/05/2018 08:05 AM

http://www.businesswire.com/news/home/20180605005936/en